These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 9160925
1. A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis. Becker B, Borum S, Nielsen K, Mygind N, Borum P. Clin Otolaryngol Allied Sci; 1997 Apr; 22(2):132-4. PubMed ID: 9160925 [Abstract] [Full Text] [Related]
5. Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea. Borum S, Becker B, Mygind N, Borum P. Rhinology; 1996 Dec; 34(4):198-200. PubMed ID: 9050095 [Abstract] [Full Text] [Related]
6. The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG, Wood CC. Allergy Asthma Proc; 1998 Dec; 19(1):23-9. PubMed ID: 9532321 [Abstract] [Full Text] [Related]
7. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. Meltzer EO, Orgel HA, Bronsky EA, Findlay SR, Georgitis JW, Grossman J, Ratner P, Wood CC. J Allergy Clin Immunol; 1992 Aug; 90(2):242-9. PubMed ID: 1386857 [Abstract] [Full Text] [Related]
11. Duration of action of intranasal atropine on methacholine-induced nasal secretions. Baroody FM, Driscoll PV, Moylan B, Fleming L, Shilstone J, Naclerio RM. Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):321-3. PubMed ID: 8607961 [Abstract] [Full Text] [Related]
12. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Georgitis JW, Banov C, Boggs PB, Dockhorn R, Grossman J, Tinkelman D, Roszko P, Wood C. Clin Exp Allergy; 1994 Nov; 24(11):1049-55. PubMed ID: 7874603 [Abstract] [Full Text] [Related]
13. Ipratropium in the treatment of patients with perennial rhinitis. Sjögren I, Juhász J. Allergy; 1984 Aug; 39(6):457-61. PubMed ID: 6238545 [Abstract] [Full Text] [Related]
14. Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies. Kim KT, Kerwin E, Landwehr L, Bernstein JA, Bruner D, Harris D, Drda K, Wanger J, Wood CC, Pediatric Atrovent Nasal Spray Study Group. Ann Allergy Asthma Immunol; 2005 Jan; 94(1):73-9. PubMed ID: 15702820 [Abstract] [Full Text] [Related]
17. Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. Naclerio RM, Baroody FM. J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1051-4. PubMed ID: 1460207 [Abstract] [Full Text] [Related]
19. Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG, Roszko P, Zegarelli E, Wood CC. J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1128-32. PubMed ID: 7751529 [Abstract] [Full Text] [Related]
20. The influence of terfenadine and ipratropium bromide alone and in combination on bradykinin-induced nasal symptoms and plasma protein leakage. Rajakulasingam K, Polosa R, Lau LC, Church MK, Holgate ST, Howarth PH. Clin Exp Allergy; 1992 Jul; 22(7):717-23. PubMed ID: 1387041 [Abstract] [Full Text] [Related] Page: [Next] [New Search]